Cite

HARVARD Citation

    Yuan, Y. et al. (2021). Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer. European journal of cancer. pp. 11-20. [Online]. 
  
Back to record